We Can Medicines Co., Ltd. (6929) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for We Can Medicines Co., Ltd. (6929:TWSE), powered by AI.

Current Price
$24.50
Sector
Consumer Defensive
What is the We Can Medicines Co., Ltd. stock price forecast?

We Can Medicines Co., Ltd. is currently trading at $24.50. View real-time AI analysis on Alpha Lenz.

What is We Can Medicines Co., Ltd. insider trading activity?

View the latest insider trading data for We Can Medicines Co., Ltd. on Alpha Lenz.

What is We Can Medicines Co., Ltd.'s P/E ratio?

View We Can Medicines Co., Ltd.'s valuation metrics on Alpha Lenz.

We Can Medicines Co., Ltd.

TWSE · 6929
NT$24.50+0.85(+3.59%)
Ask about We Can Medicines Co., Ltd.'s future dividend policy...
Alpha Chat Insight

We Can Medicines Co., Ltd.'s ROE is -6.8%. Explore profitability and growth together.

Ask for details

Company Overview

We Can Medicines Co., Ltd. is a leading operator of chain cosmeceutical drugstores in Taiwan, recognized for its extensive retail network and comprehensive product portfolio. The company’s core operations encompass the sale of pharmaceuticals, health foods, medical supplies, and daily necessities, along with specialized offerings for maternal and infant care, beauty care, and home living needs. In addition to physical retail stores, it markets products under established brands and serves customers online. Headquartered in Taichung and employing over 1,000 people, We Can Medicines Co., Ltd. plays a pivotal role in Taiwan’s consumer staples sector, consistently delivering essential healthcare and lifestyle products to a broad customer base. The company generates most of its revenue domestically and is also involved in wholesale and import activities, broadening its presence within the wider healthcare and drug retail industry.

SectorConsumer Defensive
IndustryPackaged Foods
Employees1,005

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$3.22BRevenue
0.00Shares Out
1,005Employees

Margins

33.15%Gross
8.49%EBITDA
-2.10%Operating
-2.27%Pre-Tax
-2.27%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-0.82%Rev 3Yr
3.85%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-2.41%ROA
-6.76%ROE
-1.57%ROIC

Financial Health

NT$245.36MCash & Cash Equivalents
NT$1.68BNet Debt
184.06%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

We Can Medicines Co., Ltd. (ticker: 6929) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods). It has approximately 1,005 employees.

The current price is 24.5 with a P/E ratio of -x and P/B of -x.

ROE is -6.76% and operating margin is -2.10%. Annual revenue is $3.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
We Can Medicines Co., Ltd. (6929) Stock Forecast 2026 $24.50 — Price, Financials & Analyst Targets | Alpha Lenz